YBX1 and breast carcinoma: Resistance to chemotherapeutics has been independently associated with increased CD44v6 expression [26,27], and YB-1 overexpression has already been reported to be associated with possible chemoresistance through the regulation of MDR1 in breast cancer [99] and multiple myeloma cells [104].